Cranial Stabilization Devices Market Will Create Highest Returns by 2027
The cranial nerves are stabilised during cranial stabilisation in preparation for brain surgery. Craniotomy is another name for brain surgery. The type of brain issue determines whether a craniotomy is necessary. The main purposes of this procedure are to help cure brain tumours, hematomas (blood clots), aneurysms or arteriovenous malformations (AVM), severe head injuries, foreign objects (bullets), brain edoema, or infections.
Increasing prevalence of neurological illnesses is estimated to enhance the Cranial Stabilization Devices Market growth during the forecast period. According to the 2015 Global Burden of Disease Study, neurological illnesses are the leading global cause of disability and fatality. Over the previous 25 years, from 1990 to 2015, the burden of neurological illnesses has increased by 36.7 percent.
The market expansion for cranial stabilisation devices is anticipated to be constrained by a number of issues with medical device reimbursement. The rates for medical device reimbursement in many nations are determined by standard formulae that are applied to the method or categories of devices rather than the specific technology or characteristics of each manufacturer. This discourages manufacturers of medical equipment from making investments in the creation of cutting-edge medical gadgets.
The Cranial Stabilization Devices Market in the area is anticipated to be driven by rising merger and acquisition activity in North America. For instance, Johnson & Johnson's Codman Neurosurgery division was purchased by Integra LifeSciences Holdings Corporation in October 2017. The Codman Neurosurgery company offers a selection of equipment for cranial surgery, neurointensive care, and hydrocephalus control. The transaction was completed for US$1.045 billion.
Due to increased efforts by numerous organisations to support the development of clinical neurology and neurological science in Asia Pacific, the region is also anticipated to experience considerable growth in the Cranial Stabilization Devices Market. For instance, the Asian and Oceanian Association of Neurology (AOAN) organised the conference The Asian Oceanian Congress of Neurology 2018 (AOCN 2018) in November 2018 to give attendees (neurologists) an unmatched understanding of the most recent research, developments, and treatments in the field of neurosciences through its extensive scientific programme led by local neurology experts.
Comments
Post a Comment